Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Looking for the S&P500 stocks that are experiencing notable gaps on Friday? Find out which stocks are gapping up and gapping down in the S&P500 index during today's session.
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 9.2% year on year to $766.5 million. The company’s full-year revenue guidance of $3.05 billion at the midpoint came in 3.1% above analysts’ estimates. Its non-GAAP profit of $1.84 per share was 22% above analysts’ consensus estimates.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Shares of healthcare products company West Pharmaceutical Services (NYSE:WST)
jumped 22.9% in the afternoon session after the company reported strong second-quarter 2025 financial results and raised its full-year outlook.
West Pharmaceutical raised its 2025 EPS and sales guidance after Q2 earnings and revenue topped estimates, fueled by strong demand for high-value products.
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Thursday. Discover the gap up and gap down stocks in the S&P500 index.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session.
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.2% year on year to $766.5 million. The company’s full-year revenue guidance of $3.05 billion at the midpoint came in 3.1% above analysts’ estimates. Its non-GAAP profit of $1.84 per share was 22% above analysts’ consensus estimates.
Healthcare products company West Pharmaceutical Services (NYSE:WST)
will be announcing earnings results this Thursday morning. Here’s what you need to know.
